ShareValue scores for ANUHPHR.NSE: Valuation 75, Quality 45, Growth 52, Health 57.

ANUHPHR.NSE
NSE

Anuh Pharma Limited

₹79.31(+0.11%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

14% to 29%
Valuation
75
Undervalued
Price vs Value
Quality
45
Moderate
Business Strength
Growth
52
Moderate
Revenue & Earnings
Health
57
Moderate
Financial Stability
Momentum
58
Neutral
Price Trend

Company Details

About

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026